Dr. Rebecca L. Manno, MD

Dr. Manno practices at Comprehensive Orthopedic Global in Henderson, Nevada.

Dr. Manno's NPI, 1871717652, was assigned on April 12, 2007. Dr. Manno graduated from University of Maryland School of Medicine - Baltimore in 2003. Dr. Manno's Maryland license number on file is D64017.

Dr. Manno's primary practice is Comprehensive Orthopedic Global, at 1887 Whitney Mesa Dr, Henderson, NV 89014 in Clark County. The practice phone is (340) 779-2663.

Dr. Manno's primary practice is Comprehensive Orthopedic Global in Henderson, Nevada. Dr. Manno is also affiliated with Roy Lester Schneider Hospital. The medical group on file is Comprehensive Orthopaedic Global. Dmand AI also links Dr. Manno to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manno practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Manno's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Manno is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Manno's licenses on file in 2 states: Maryland and U.S. Virgin Islands.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint arthropathy, joint pain, lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Manno treats.

CMS data shows 714 Medicare services from Dr. Manno across 2 procedure codes in 2024, all of them office visits, for 253 Medicare patients. Medicare paid $59,786 for them. Every service was in an office.

CMS counts 253 Medicare patients who saw Dr. Manno in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have arthritis, and 69% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Manno's median patient age at 65, with 81% women.

In 2024, Dr. Manno wrote 1,241 Medicare Part D claims for 187 patients. 86% of them were for generic drugs. CMS names the drug for 980 of them, across 22 drugs with 11 or more claims each, at $782,409 in total drug cost. In 2023, CMS named 978 claims across 19 drugs.

Dr. Manno accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 27 papers to Dr. Manno, published from 2011 to 2021. 2018 was the busiest year, with 8. The most frequent topics are Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Cyclophosphamide and Immunosuppressive Agents. Dr. Manno has published most often in Cureus. Dr. Manno's most frequent co-authors are Homa Timlin, MD, Uzma Jala Haque, MD and Clifton O. Bingham.

Dmand AI links Dr. Manno to 1 clinical trial. Conditions studied include Arthritis, Rheumatoid and Rheumatic Diseases.

CMS Open Payments shows 24 general payments to Dr. Manno from 3 drug and device companies from 2017 to 2018. Consulting fees make up the largest share, 60% of the total. Genentech, Inc. paid the most, $7,825.

Dmand AI lists 2 awards for Dr. Manno, most recently CMS Stage 1 EHR in 2013.

Dr. Manno graduated from University of Maryland School of Medicine - Baltimore in 2003. Dr. Manno is a member of ACR.

Dr. Manno is in network with 2 carriers, including CMS Medicare and DE State Medicaid. Medicaid plans come from the most carriers, 1. Check the plan with the practice before a visit.